Halotestin – Fluoxymesterone 10mg
Halotestin is presented in the ORYVION catalog as a tablet formulation containing 10mg of fluoxymesterone per tablet, supplied in containers of 25 tablets. Fluoxymesterone is an orally active androgen with a reported elimination half-life of approximately 9.2 hours.
Its pharmacological profile includes androgenic effects and changes in protein metabolism and nitrogen retention. These actions also affect hormonal regulation: exposure to external androgens can inhibit the body’s own testosterone production and suppress sperm production.
Product Specifications:
Commercial name: Halotestin
Listed compound: Fluoxymesterone
Declared strength: 10mg per tablet
Format: Tablets
Package contents: 25 tablets
Important Note:
Fluoxymesterone can cause serious liver injury, adverse cholesterol changes, and suppression of natural testosterone and sperm production.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.